Abstract
In this study, the impact of stationary phase chemistry was investigated for the analysis of large biomolecules. For this purpose, widepore state-of the-art C18, C3, diphenyl stationary phases as well as a new superficially porous material possessing a carbon core and nanodiamond-polymer shell (composite material) were tested. To evaluate the similarities and differences between these phases, two samples were considered, including i) oxidatively stressed and reduced recombinant interferon alfa-2A variants as well as ii) light chain and heavy chain fragments of a human IgG1 monoclonal antibody Belimumab. For both samples, the overall selectivity was found to be similar on all the silica-based stationary phases (e.g. α = 1.20 - 1.25 between the two oxidized forms of interferon), while it was somewhat different on the composite material (α = 1.12 between the two oxidized forms of interferon). On the other hand, the kinetic performance of the composite phase was somewhat lower (peak capacity between 70 and 80) than that of silica-based materials (peak capacity higher than 100), except in the presence of a relatively high concentration TFA (0.5% TFA) due to the reduction of ionic interactions. At the end, when separating closely eluting proteins variants in RPLC mode, minor differences in selectivity may be more important than kinetic efficiency and therefore, the composite material might also be of interest for biomolecules characterization.
Keywords: Carbon/nanodiamond/polymer shell particles, kinetic performance, protein separation, reversed phase chromatography, selectivity.
Current Chromatography
Title:Comparative Study on Selectivity and Kinetic Performance of Recent Reversed Phase Liquid Chromatography Columns in the Separation of Protein Variants
Volume: 2
Author(s): Balazs Bobaly, Zoltan Marta, Jeno Fekete, Davy Guillarme and Szabolcs Fekete
Affiliation:
Keywords: Carbon/nanodiamond/polymer shell particles, kinetic performance, protein separation, reversed phase chromatography, selectivity.
Abstract: In this study, the impact of stationary phase chemistry was investigated for the analysis of large biomolecules. For this purpose, widepore state-of the-art C18, C3, diphenyl stationary phases as well as a new superficially porous material possessing a carbon core and nanodiamond-polymer shell (composite material) were tested. To evaluate the similarities and differences between these phases, two samples were considered, including i) oxidatively stressed and reduced recombinant interferon alfa-2A variants as well as ii) light chain and heavy chain fragments of a human IgG1 monoclonal antibody Belimumab. For both samples, the overall selectivity was found to be similar on all the silica-based stationary phases (e.g. α = 1.20 - 1.25 between the two oxidized forms of interferon), while it was somewhat different on the composite material (α = 1.12 between the two oxidized forms of interferon). On the other hand, the kinetic performance of the composite phase was somewhat lower (peak capacity between 70 and 80) than that of silica-based materials (peak capacity higher than 100), except in the presence of a relatively high concentration TFA (0.5% TFA) due to the reduction of ionic interactions. At the end, when separating closely eluting proteins variants in RPLC mode, minor differences in selectivity may be more important than kinetic efficiency and therefore, the composite material might also be of interest for biomolecules characterization.
Export Options
About this article
Cite this article as:
Bobaly Balazs, Marta Zoltan, Fekete Jeno, Guillarme Davy and Fekete Szabolcs, Comparative Study on Selectivity and Kinetic Performance of Recent Reversed Phase Liquid Chromatography Columns in the Separation of Protein Variants, Current Chromatography 2015; 2 (2) . https://dx.doi.org/10.2174/2213240602666150518234925
DOI https://dx.doi.org/10.2174/2213240602666150518234925 |
Print ISSN 2213-2406 |
Publisher Name Bentham Science Publisher |
Online ISSN 2213-2414 |
Related Articles
-
Specific Targeted Therapy: A New Tool for the Destruction of Cancer
Current Drug Therapy Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Current Cancer Drug Targets Does the Septic Shock Interfere Experimental Acute Pancreatitis in Rats?
Medicinal Chemistry New Targeted Therapies for Anaplastic Thyroid Cancer
Anti-Cancer Agents in Medicinal Chemistry Kinase Inhibitors Targeting Anti-angiogenesis as Anti-cancer Therapies
Current Angiogenesis (Discontinued) Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety
Current Pharmaceutical Design Histone Deacetylase Inhibitors: Novel Immunomodulators
Current Enzyme Inhibition A Meta-Analysis and Systematic Review on the Effect of Probiotics in Acute Diarrhea
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacokinetics of Antifungal Agents in Neonates and Young Infants
Current Medicinal Chemistry Measuring T Cell Cytokines in Allergic Upper and Lower Airway Inflammation: Can We Move to the Clinic?
Inflammation & Allergy - Drug Targets (Discontinued) Banking Strategies for Improving the Hematopoietic Stem Cell Content of Umbilical Cord Blood Units for Transplantation
Current Stem Cell Research & Therapy The Guanylyl Cyclase Inhibition by MB as Vasoplegic Circulatory Shock Therapeutical Target
Current Drug Targets Molecular Biomarkers for Amyotrophic Lateral Sclerosis
Current Bioinformatics Mechanisms of Neuropathic Pain
Current Medicinal Chemistry - Central Nervous System Agents Stress and the α7 Nicotinic Acetylcholine Receptor
Current Drug Targets Causal Mechanisms Underlying Periventricular Leukomalacia and Cerebral Palsy
Current Pediatric Reviews Discovery of Potent, Non-Steroidal and Highly Selective Glucocorticoid Receptor Antagonists with Anti-Obesity Activity
Letters in Drug Design & Discovery The GP120 Molecule of HIV-1 and its Interaction with T Cells
Current Medicinal Chemistry Nanoparticles of Lyotropic Liquid Crystals: A Novel Strategy for the Topical Delivery of a Chlorin Derivative for Photodynamic Therapy of Skin Cancer
Current Nanoscience Recent Advances in the Treatment of Helicobacter pylori Infection
Recent Patents on Anti-Infective Drug Discovery